מרופנם אנפארם 500 מג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

MEROPENEM AS TRIHYDRATE

Disponible desde:

K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL

Código ATC:

J01DH02

formulario farmacéutico:

אבקה להמסה להזרקה\אינפוזיה

Composición:

MEROPENEM AS TRIHYDRATE 500 MG/VIAL

Vía de administración:

תוך-ורידי

tipo de receta:

מרשם נדרש

Fabricado por:

ANFARM HELLAS S.A., GREECE

Grupo terapéutico:

MEROPENEM

Área terapéutica:

MEROPENEM

indicaciones terapéuticas:

Meropenem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis -Septicemia. Meropenem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency

Fecha de autorización:

2018-07-31